CHD

Latest News

Revascularization Type Not Linked to Changes in Rate of Memory Decline

The study objective was to compare the change in the rate of memory decline after PCI vs CABG.

Low- and High-Dose Aspirin Similarly Effective in ASCVD

For patients with established atherosclerotic cardiovascular disease, there is no significant difference in cardiovascular events or major bleeding for those receiving 81 mg or 325 mg of aspirin daily.

Remnant Cholesterol Predicts Cardiovascular Events Among Patients With Coronary Artery Disease

Austrian researchers investigated the utility of remnant cholesterol as a marker of cardiovascular event risk in coronary artery disease.

Subclinical Hypothyroidism Not Associated With Higher Mortality Rates in Older Patients Post Angioplasty

Subclinical hypothyroidism is reportedly associated with an increased risk of adverse events in patients undergoing coronary angioplasty.

Mortality Lower With PDE5i Treatment in Men With Stable CAD

Mortality risk lower with PDE5i treatment versus alprostadil treatment; similar links seen for MI, heart failure, CV mortality risk.

Potent Up-Front Antiplatelet Therapy Lowers Mortality for Patients With ACS

Researchers compared a potent antiplatelet inhibition strategy with a less potent inhibition treatment plan in patients with acute coronary syndrome undergoing coronary artery bypass surgery.

Recurrent CHD Risk Up With Long Working Hours After First MI

For patients returning to work after first myocardial infarction, the risk for recurrent coronary heart disease.

Current Smoking Linked to Increase in CHD Risk in African-Americans

Compared with never smokers, current smokers have increased odds of having coronary artery calcification score.

FDA Approves First Nonsurgical Heart Valve for Congenital Heart Disease

The Harmony TPV System provides less invasive option to treat pulmonary regurgitation in patients with native or surgically repaired right ventricular outflow tract.

US Patterns for Recurrent Coronary Heart Disease Examined

From 2008 to 2017, the rates of cardiovascular diseases declined in the year after MI, with greater reductions seen for women than men.